{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T14:53:29Z","timestamp":1788274409676,"version":"build-2803163510"},"reference-count":24,"publisher":"Impact Journals, LLC","issue":"51","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,12,20]]},"DOI":"10.18632\/oncotarget.13139","type":"journal-article","created":{"date-parts":[[2016,11,5]],"date-time":"2016-11-05T19:20:08Z","timestamp":1478373608000},"page":"84587-84593","source":"Crossref","is-referenced-by-count":14,"title":["FGFR3, as a receptor tyrosine kinase, is associated with differentiated biological functions and improved survival of glioma patients"],"prefix":"10.18632","volume":"7","author":[{"given":"Zheng","family":"Wang","sequence":"first","affiliation":[{"name":"Beijing Neurosurgical Institute, Capital Medical University, Beijing, China"},{"name":"Beijing Tiantan Hospital, Capital Medical University, Beijing, China"},{"name":"Chinese Glioma Genome Atlas network (CGGA), Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanbao","family":"Zhang","sequence":"additional","affiliation":[{"name":"Beijing Neurosurgical Institute, Capital Medical University, Beijing, China"},{"name":"Beijing Tiantan Hospital, Capital Medical University, Beijing, China"},{"name":"Chinese Glioma Genome Atlas network (CGGA), Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihua","family":"Sun","sequence":"additional","affiliation":[{"name":"Beijing Neurosurgical Institute, Capital Medical University, Beijing, China"},{"name":"Chinese Glioma Genome Atlas network (CGGA), Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingshan","family":"Liang","sequence":"additional","affiliation":[{"name":"Beijing Neurosurgical Institute, Capital Medical University, Beijing, China"},{"name":"Chinese Glioma Genome Atlas network (CGGA), Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Liu","sequence":"additional","affiliation":[{"name":"Beijing Neurosurgical Institute, Capital Medical University, Beijing, China"},{"name":"Beijing Tiantan Hospital, Capital Medical University, Beijing, China"},{"name":"Chinese Glioma Genome Atlas network (CGGA), Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanzhang","family":"Li","sequence":"additional","affiliation":[{"name":"Beijing Neurosurgical Institute, Capital Medical University, Beijing, China"},{"name":"Beijing Tiantan Hospital, Capital Medical University, Beijing, China"},{"name":"Chinese Glioma Genome Atlas network (CGGA), Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Yao","sequence":"additional","affiliation":[{"name":"Sanbo Brain Hospital, Capital Medical University, Beijing, China"},{"name":"Chinese Glioma Genome Atlas network (CGGA), Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Beijing Tiantan Hospital, Capital Medical University, Beijing, China"},{"name":"Center of Brain Tumor, Beijing Institute for Brain Disorders, Beijing, China"},{"name":"China National Clinical Research Center for Neurological Diseases, Beijing, China"},{"name":"Chinese Glioma Genome Atlas network (CGGA), Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Jiang","sequence":"additional","affiliation":[{"name":"Beijing Neurosurgical Institute, Capital Medical University, Beijing, China"},{"name":"Beijing Tiantan Hospital, Capital Medical University, Beijing, China"},{"name":"Center of Brain Tumor, Beijing Institute for Brain Disorders, Beijing, China"},{"name":"China National Clinical Research Center for Neurological Diseases, Beijing, China"},{"name":"Chinese Glioma Genome Atlas network (CGGA), Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,11,5]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.canlet.2016.01.024","article-title":"CGCG clinical practice guidelines for the management of adult diffuse gliomas","volume":"375","author":"Li","year":"2016","journal-title":"Cancer Lett"},{"key":"2","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/nrc2088","article-title":"Epidermal growth factor receptor mutations in lung cancer","volume":"7","author":"Haber","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"3","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1038\/onc.2009.198","article-title":"Activating and resistance mutations of EGFR in non-small-cell lung cancer: role in clinical response to EGFR tyrosine kinase inhibitors","volume":"28","author":"Gazdar","year":"2009","journal-title":"Oncogene"},{"key":"4","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/nature13480","article-title":"Comprehensive molecular characterization of gastric adenocarcinoma","volume":"513","author":"Cancer Genome Atlas Research","year":"2014","journal-title":"Nature"},{"key":"5","first-page":"972","article-title":"EGFR has a tumour-promoting role in liver macrophages during hepatocellular carcinoma formation","volume":"16","author":"Wang","journal-title":"Nat Cell Biol"},{"key":"6","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/ng.2734","article-title":"The integrated landscape of driver genomic alterations in glioblastoma","volume":"45","author":"Porrati","year":"2013","journal-title":"Nat Genet"},{"key":"7","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ccr.2009.12.020","article-title":"Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1","volume":"17","author":"O\u2019Kelly","year":"2010","journal-title":"Cancer Cell"},{"key":"8","doi-asserted-by":"crossref","first-page":"4846","DOI":"10.1038\/ncomms5846","article-title":"The landscape of kinase fusions in cancer","volume":"5","author":"Lengauer","year":"2014","journal-title":"Nat Commun"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Bao, Chen, Yang, Zhang, Yu, Ye, Hu, Yan, Zhang, Akers, Ramakrishnan, Li, Carter, et al. RNA-seq of 272 gliomas revealed a novel, recurrent PTPRZ1-MET fusion transcript in secondary glioblastomas. Genome Res. 2014.","DOI":"10.1101\/gr.165126.113"},{"key":"10","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1126\/science.1220834","article-title":"Transforming fusions of FGFR, TACC genes in human glioblastoma","volume":"337","author":"Ceccarelli","year":"2012","journal-title":"Science"},{"key":"11","first-page":"855","article-title":"The tumorigenic FGFR3-TACC3 gene fusion escapes miR-99a regulation in glioblastoma","volume":"123","author":"Visakorpi","year":"2013","journal-title":"J Clin Invest"},{"key":"12","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1158\/1078-0432.CCR-11-0699","article-title":"Molecular pathways: fibroblast growth factor signaling: a new therapeutic opportunity in cancer","volume":"18","author":"Smith","year":"2012","journal-title":"Clin Cancer Res"},{"key":"13","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/path.4334","article-title":"Fibroblast growth factor receptor 3 activation plays a causative role in urothelial cancer pathogenesis in cooperation with Pten loss in mice","volume":"233","author":"Iwata","year":"2014","journal-title":"J Pathol"},{"key":"14","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1242\/dmm.006874","article-title":"K-Ras and beta-catenin mutations cooperate with Fgfr3 mutations in mice to promote tumorigenesis in the skin and lung, but not in the bladder","volume":"4","author":"Iwata","year":"2011","journal-title":"Dis Model Mech"},{"key":"15","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/1476-4598-12-83","article-title":"FGFR3 has tumor suppressor properties in cells with epithelial phenotype","volume":"12","author":"Moreau-Gaudry","year":"2013","journal-title":"Mol Cancer"},{"key":"16","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s00428-014-1672-9","article-title":"Increased angiogenesis and FGFR protein expression indicate a favourable prognosis in bladder cancer","volume":"465","author":"Gaumann","year":"2014","journal-title":"Virchows Arch"},{"key":"17","doi-asserted-by":"publisher","first-page":"16636","DOI":"10.18632\/oncotarget.7674","article-title":"p85alpha promotes nucleolin transcription and subsequently enhances EGFR mRNA stability and EGF-induced malignant cellular transformation","volume":"7","author":"Huang","year":"2016","journal-title":"Oncotarget"},{"key":"18","doi-asserted-by":"publisher","first-page":"8184","DOI":"10.18632\/oncotarget.6945","article-title":"p38 MAPK-induced MDM2 degradation confers paclitaxel resistance through p53-mediated regulation of EGFR in human lung cancer cells","volume":"7","author":"Lee","year":"2016","journal-title":"Oncotarget"},{"key":"19","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1016\/S0002-9440(10)64665-2","article-title":"Frequent FGFR3 mutations in papillary non-invasive bladder (pTa) tumors","volume":"158","author":"van der Kwast","year":"2001","journal-title":"Am J Pathol"},{"key":"20","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/path.1202","article-title":"Frequent FGFR3 mutations in urothelial papilloma","volume":"198","author":"van der Kwast","year":"2002","journal-title":"J Pathol"},{"key":"21","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.1158\/1078-0432.CCR-14-2199","article-title":"Detection, Characterization, and Inhibition of FGFR-TACC Fusions in IDH Wild-type Glioma","volume":"21","author":"Belaid","year":"2015","journal-title":"Clin Cancer Res"},{"key":"22","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1093\/bioinformatics\/btu393","article-title":"circlize Implements and enhances circular visualization in R","volume":"30","author":"Brors","year":"2014","journal-title":"Bioinformatics"},{"key":"23","unstructured":"TT. A Package for Survival Analysis in S. version 2.38. 2015."},{"key":"24","doi-asserted-by":"publisher","first-page":"40896","DOI":"10.18632\/oncotarget.5683","article-title":"IDH mutation and MGMT promoter methylation in glioblastoma: Results of a prospective registry","volume":"6","author":"Li","year":"2015","journal-title":"Oncotarget"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.13139","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T14:09:20Z","timestamp":1596722960000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.13139"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,5]]},"references-count":24,"journal-issue":{"issue":"51","published-print":{"date-parts":[[2016,12,20]]}},"alternative-id":["13139","27829236"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.13139","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,5]]}}}